Angiomyolipoma epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3], Rekha, M.D.
Overview
Overview
The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence
- Angiomyolipoma occurs in more than 70% of cases with renal manifestations of tuberous sclerosis.[1][2][3]
Incidence
- The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide.
Gender
- Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.
Age
- Angiomyolipoma commonly affects individuals older than 40 years of age.[4]
References
References
- ↑ Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). “Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors”. Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
- ↑ Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). “Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors”. Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
- ↑ Bissler JJ, Kingswood JC (2004). “Renal angiomyolipomata”. Kidney Int. 66 (3): 924–34. doi:10.1111/j.1523-1755.2004.00838.x. PMID 15327383.
- ↑ Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010). “Trends of presentation and clinical outcome of treated renal angiomyolipoma”. Yonsei Med J. 51 (5): 728–34. doi:10.3349/ymj.2010.51.5.728. PMC 2908871. PMID 20635448.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH